Table 4.
Metabolite
|
Pathway
|
Microbial agent
|
Health benefits
|
Butyrate | Carbohydrate metabolism | Clostridia; Faecalibacterium prausnitzii; Coprococcus catus; Anaerostipes hadrus | Increased intestinal barrier function; Modulate intestinal macrophage function; Suppression of colonic inflammation; Improvements in insulin sensitivity |
Propionate | Carbohydrate metabolism | Blautia obeum; Coprococcus catus; Roseburia inulinivorans; Prevotella copri | Suppression of colonic inflammation; Decreased innate immune response to microbial stimulation; Protection from allergic airway inflammation; Improvements in insulin sensitivity and weight control in obese mice |
Indole | Tryptophan metabolism | Lactobacillus; Bifinobacterium longum; Bacteroides fragilis | Maintenance of host-microbe homeostasis at mucosal surfaces via IL-22; Increased barrier function; Modulation of host metabolism |
Indole-3-aldehyde | Tryptophan metabolism | Lactobacillus | Maintenance of mucosal homeostasis and intestinal barrier function via increased IL-22 production; Protection against intestinal inflammation in mouse models of colitis |
Indole-3-propionate | Tryptophan metabolism | Clostridium sporogenes | Maintenance of intestinal barrier function and mucosal homeostasis; Increased production of antioxidant and neuroprotectant products |
10-hydroxy-cis-12-octadecoate | Linoleic acid derivative (lipid metabolism) | Lactobacillus | Maintenance of intestinal barrier function; Decreased inflammation; Increased intestinal IgA production |
IgA: Immunoglobulin A; IL-22: Interleukin 22.